Patents by Inventor Barry Howard Carter

Barry Howard Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION
    Publication number: 20160143909
    Abstract: Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
    Type: Application
    Filed: January 29, 2016
    Publication date: May 26, 2016
    Applicant: Novartis AG
    Inventors: Barry Howard Carter, Dwayne A. Campbell
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20140335177
    Abstract: Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
    Type: Application
    Filed: July 28, 2014
    Publication date: November 13, 2014
    Inventors: Barry Howard Carter, Dwayne A. Campbell
  • Pharmaceutical composition
    Patent number: 8821927
    Abstract: Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: September 2, 2014
    Assignee: SmithKline Beecham (Cork) Limited
    Inventors: Barry Howard Carter, Dwayne A Campbell
  • Pharmaceutical Composition
    Publication number: 20080206330
    Abstract: Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
    Type: Application
    Filed: April 18, 2006
    Publication date: August 28, 2008
    Inventors: Barry Howard Carter, Dwayne A. Campbell
  • Guanine derivative
    Patent number: 6107302
    Abstract: The invention relates to an anhydrous crystalline form of (2-[2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy]ethyl L-valinate hydrochloride (otherwise known as valaciclovir hydrochloride) and a process for preparing it.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: August 22, 2000
    Assignee: Glaxo Wellcome Inc.
    Inventors: Barry Howard Carter, Jane Muse Partin, Peter Gregory Varlashkin, Richard Augustus Winnike, William Bayne Grubb, III, Gregory Alan Conway, Philip George Lake, David Michael Skinner, David James Whatrup
  • Valaciclovir tablets containing colloidal silicon dioxide
    Patent number: 5879706
    Abstract: A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a lubricant and a microcrystalline cellulose filler are present extragranularly has excellent hardness and friability properties while still maintaining lubrication of the tablet granules.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: March 9, 1999
    Assignee: Glaxo Wellcome Inc.
    Inventors: Barry Howard Carter, Lloyd Gary Tillman